Skip to main content
MedPathMedPath Home
Clinical Trials/NCT00407173
NCT00407173
Completed
Phase 1

An Open-Label, Single-Dose, Parallel Group Study to Evaluate the Effects of Age and Gender on the Pharmacokinetics, Safety, and Tolerability of HCV-796 Administered Orally to Healthy Subjects

Wyeth is now a wholly owned subsidiary of Pfizer0 sites48 target enrollmentNovember 2006
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsHealthy
InterventionsHCV-796
DrugsHCV-796

Overview

Phase
Phase 1
Intervention
HCV-796
Conditions
Healthy
Sponsor
Wyeth is now a wholly owned subsidiary of Pfizer
Enrollment
48
Primary Endpoint
To evaluate the pharmacokinetic (PK) profile of HCV-796 in healthy men and women of different ages.
Status
Completed
Last Updated
18 years ago
OverviewInvestigatorsEligibility CriteriaArms & InterventionsOutcomesSimilar Trials

Overview

Brief Summary

This study is an open-label, single-dose, parallel group study to evaluate the effects of age and gender on the pharmacokinetics, safety, and tolerability of HCV-796 administered orally to healthy subjects.

Registry
clinicaltrials.gov
Start Date
November 2006
End Date
June 2007
Last Updated
18 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Sponsor
Wyeth is now a wholly owned subsidiary of Pfizer

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Not provided

Arms & Interventions

1

HCV-796 1000mg single dose

Intervention: HCV-796

Outcomes

Primary Outcomes

To evaluate the pharmacokinetic (PK) profile of HCV-796 in healthy men and women of different ages.

Time Frame: 7 days

Secondary Outcomes

  • To assess the safety and tolerability of a single oral dose of HCV-796 in healthy men and women of different ages.(15 days)

Similar Trials

Completed
Phase 1
Effects of Age and Sex on the Pharmacokinetics of Apremilast in Healthy AdultsHealthy Volunteer
NCT01634191Amgen36
Completed
Phase 1
Study to Assess Effects of Age, Weight, and Body Composition on the Pharmacokinetics of IV Diclofenac SodiumHealthy
NCT00509743Javelin Pharmaceuticals89
Withdrawn
Not Applicable
Clinical Trial to Assess the Influence of Gestational Stage and Maternal Age on Arterial Stiffness of the MotherPregnancy Trimester, FirstPregnancy Trimester, SecondPregnancy Trimester, Third
NCT00180219Technische Universität Dresden
Recruiting
Not Applicable
Multidisciplinary Evaluation of Elderly Patients With Digestive Cancer (EPODIG-G)Digestive System DiseaseNeoplasms
NCT05066139Centre Paul Strauss144
Completed
Not Applicable
Heat Wrap Device Safety With Age and Body FatBack Pain
NCT01355653Pfizer45